RT Journal Article
SR Electronic
T1 The Business of Quality: Evaluating the Impact of Healthcare Quality Improvements on Staff Numbers and Patient Utilization in Sub-Saharan Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.03.23285375
DO 10.1101/2023.02.03.23285375
A1 Gloria P. Gómez-Pérez
A1 Daniëlla Brals
A1 Aafke E. de Graaff
A1 Ibironke Dada
A1 Bonifacia Benefo Agyei
A1 Peter Risha
A1 Elizabeth Bonareri
A1 John T. Dekker
A1 Tobias F. Rinke de Wit
A1 Nicole Spieker
A1 Wendy Janssens
YR 2023
UL http://medrxiv.org/content/early/2023/02/07/2023.02.03.23285375.abstract
AB Every year an estimated 5 to 8 million people die in low- and middle-income countries (LMICs) due to poor-quality care. Although quality improvements in healthcare facilities in LMICs are well-possible with tailored implementation plans, costs are often mentioned as a prohibiting factor. However, if quality improvements increase trust among patients, this might translate into increased visits and higher revenues for providers and enable them to further invest in quality. This paper assesses the potential business case of quality improvements in Sub-Saharan Africa (SSA). It focuses on both the public and private sector since the latter provides at least half of all health services in SSA. The analysis is based on a dataset including multiple assessments of quality and business performance indicators for almost 500 health facilities in Tanzania, Kenya, Ghana, Nigeria, and other SSA-countries. We studied the association between changes in quality assessment scores and subsequent changes in numbers of patient visits and staff as proxies for business growth. We found that quality improvements significantly improved business performance indicators, but only for those facilities that had already reached a certain level of quality to begin with. These findings suggest an S-shaped relationship between quality and business performance, leading to the existence of a ‘low-quality trap’. Substantial financial investments might be needed initially to support facilities at the bottom of the distribution in reaching a basic level of quality, after which further quality investments may start translating into increased revenues, enhancing business performance.Key messagesMillions of people die every year in low- and middle-income countries (LMICs) due to low quality of careTo reach Universal Health Coverage, drastic quality improvements are essentialAchieving quality of care in LMICs is possible but challenging because it requires substantial financial investments, specialized skills and sufficient human resourcesWe found there is a business case for quality investments in SSA, as quality improvements are associated with a significant increase in the number of patient visits and staff over time, indicative of greater revenue streams and financial capacityTargeted financing programmes together with technical assistance to healthcare facilities are critical to drive quality investments, especially for facilities at the beginning of their quality improvement journeysCompeting Interest StatementSome authors are current employees of PharmAccess Foundation, an institution discussed in this article. These affiliations are explicitly listed in the article.Funding StatementThis work was supported by the Health Insurance Fund of the Minister of Foreign Affairs of The Netherlands.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.